MYADM and pulmonary arterial hypertension: Considering the role of miR-182-3p/Myadm on vascular smooth muscle cell (VSMC) proliferation and pathological progression of SMC hyperproliferation in the peripheral and pulmonary arteries, we hypothesized that myeloid-derived miR-182-3p/Myadm affect PASMC proliferation, leading to the development of vascular remodeling in PAH.